本次公开发行情况               发行价（元/股）                                                                                                                                                                                                                                                                                   5.4                                                           停牌前收盘价（元/股）    5.33

                               发行市盈率                                                                                                                                                                                                                                                                                        22.90倍                                                       停牌前总市值（亿元）     19.56

                               定价方式                                                                                                                                                                                                                                                                                          询价                                                          募集资金总额（亿元）     3.24

                               是否向战略投资者配售                                                                                                                                                                                                                                                                              六名战略投资者共获配925.93万股，约占本次发行总规模的15.43%                                 

财务表现                       营业收入（亿元）                                                                                                                                                                                                                                                                                  3.84                                                          3.85                     5.07

（2017年-2019年）                                                                                                                                                                                                                                                                                                                                                                                                           

                               归母净利润（万元）                                                                                                                                                                                                                                                                                4598.79                                                       4685.96                  10558.57

                               毛利率                                                                                                                                                                                                                                                                                            37.96%                                                        38.34%                   44.47%

本次募资用途                   特色原料药的新、改、扩建设项目和补充流动资金                                                                                                                                                                                                                                                                                                                                                 

主营业务简介                   公司主营业务为化学原料药、医药中间体及含氧杂环类化工中间体的研发、生产及销售，其中原料药主要涵盖抗肿瘤类原料药、解热镇痛抗炎类原料药、抗癫痫类原料药等；医药中间体产品主要涵盖抗艾滋病类医药中间体、抗癫痫类医药中间体、抗肿瘤类医药中间体等；含氧杂环类化工中间体主要包括二氧五环、二氧六环。